scholarly journals Febuxostat is useful for cancer-associated hyperuricemia in patients with hematologic malignancies

2018 ◽  
Vol 42 (2) ◽  
pp. 157-164
Author(s):  
Kana Oiwa ◽  
Mihoko Morita ◽  
Misato Kawamichi ◽  
Kei Fujita ◽  
Shin Lee ◽  
...  
Keyword(s):  
Hematologic Malignancies

Author response for "Should we screen patients with hematologic malignancies for COVID ‐19?"

2020 ◽  
Author(s):  
Elie Rassy ◽  
Rita‐Maria Khoury‐Abboud ◽  
Nathalie Ibrahim ◽  
Tarek Assi ◽  
Bachar Samra ◽  
...  
Keyword(s):  
Hematologic Malignancies ◽  
Author Response

Adoptive Cell Therapy for Gastrointestinal Cancers

2020 ◽  
Vol 04 (04) ◽  
pp. 345-350
Author(s):  
Ryan J. Slovak ◽  
Hyun S. Kim
Keyword(s):  
Cell Therapy ◽  
Clinical Research ◽  
Solid Tumors ◽  
Immune Cells ◽  
Ex Vivo ◽  
Adoptive Cell Therapy ◽  
Hematologic Malignancies ◽  
Gastrointestinal Cancers ◽  
Gastrointestinal Malignancies ◽  
Specific Antigens

AbstractThe reinfusion of autologous or allogeneic immune cells that have been educated and/or engineered ex vivo to respond to tumor-specific antigens is termed “adoptive cell therapy.” While adoptive cell therapy has made tremendous strides in the treatment of hematologic malignancies, its utilization for solid tumors has lagged somewhat behind. The purpose of this article is to concisely review the clinical research that has been done to investigate adoptive cell therapy as a treatment for gastrointestinal malignancies.

Sign in / Sign up

Export Citation Format

Share Document